HES1 and hepatocellular carcinoma: In HCC-1954 cells, treatment with CompE caused a decrease in both HES-1 and HEY-1 transcript levels, whereas in HCC-2218 cells, the treatment only inhibited HEY-1 transcript levels (Fig. 5d).